Languages

Japanese

• Mergers and Acquisitions
  • Mergers and Acquisitions/Reorganizations
  • Private Equity
  • Venture Capital/Start-ups
• Finance
  • LBO Finance
  • Capital Markets
• Regulatory/Regulated Transactions
  • Financial Regulation
• Health Care, Pharmaceuticals and Medical Sciences

Jan. 6, 2012 Firm News

13 new lawyers joined Mori Hamada & Matsumoto

View All

2012/07

Renewable Energy Act: METI Ordinance, announcement and response to public comments

View All

Jan. 29, 2020MHM Seminars

"Digital Health and Law"

Jan. 27, 2020MHM Seminars

"Digital Health and Law"

Jan. 21, 2020MHM Seminars

"Digital Health and Law"

View All

Magazine Article

"Efforts for Making Civil Case Decisions Available as Open Data and its Potential Utilization - Global Trends, Current Efforts and Outlook in Japan"

Article

"Getting the Deal Through - Healthcare M&A 2020 - Japan Chapter"

Book Article

"Q&A: Digital Health and Law"

View All

• The University of Tokyo (LL.B., 2007)
• The University of Tokyo, School of Law (J.D., 2010)
• Seconded to Tokyo Stock Exchange, Inc. (2013-2014)
• Cornell Law School (LL.M., 2018)
• with Kirkland & Ellis LLP, Chicago (2018-2019)
• seconded to the Pharmaceutical Safety and Environmental Health Bureau （Compliance and Narcotics Division, Pharmaceutical Evaluation Division, and Medical Device Evaluation Division） of the Ministry of Health, Labour and Welfare（2020-）